Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109147) titled 'SPF of Iberia Keyci Invisiblock Advanced Fluid Sunscreen' on April 23.
Study Type: PMS
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Iberia Pharmaceuticals India Ltd.
Intervention:
Intervention1: Test Product: Keyci Invisiblock Advanced Fluid Sunscreen: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour
Control Intervention1: Reference Sunscreen: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 ho...